Insulin, specifically glucose-potassium-insulin (GKI) infusions, have been shown to be feasible and safe in acute stroke patients.[150, 151] Insulin appears to have beneficial effects, including anti-inflammatory, antioxidant and nitric oxide effects, which are independent of its ability to lower glucose levels, and which may be beneficial in stroke.[152]. This evidence concerns the gene INS and stroke disorder.